James Fossetta

Statistics

Publications

Citations

1.3K

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Inflammation Research Foundation

New Jersey Urology

Bloomfield College

United States Pharmacopeial Convention

James Fossetta is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1988–2016

Publications

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Thierry Fischmann, Alan Hruza, Xiao Da Niu et al. · Nature Structural Biology · 1999 · 456 citations

Life Sciences, Biochemistry, Molecular Biology +10

Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist

Waldemar Gonsiorek, Xuedong Fan, David Hesk et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 130 citations

Life Sciences, Immunology, Pharmacology +17

Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer, Younong Yu, Jianping Chao et al. · Journal of Medicinal Chemistry · 2006 · 116 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

The carboxyl-terminal region of human interferon γ is important for biological activity: mutagenic and NMR analysis

Daniel Lundell, Charles A. Lunn, David C. Dalgarno et al. · Protein Engineering Design and Selection · 1991 · 67 citations

Natural Sciences, Biochemistry, Molecular Biology +6

Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells

James Fossetta, James Jackson, Gregory Deno et al. · Molecular Pharmacology · 2003 · 63 citations

Life Sciences, Immunology, Pharmacology +17

1–5 of 23